EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

KPX Chemical (025000) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of KPX Chemical KRW 124,260, price KRW 56,600, upside +119.5%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Basic Materials · KR · ISIN KR7025000001

KC Some data Oct 2, 2026

KPX Chemical

025000 · KO

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

Fair value 124,260 KRW · Strongly undervalued (+119.5%)
Quality 60/100
Solidly profitable · 12.3% net margin (TTM)
Low debt
Generates free cash flow
7.5% dividend yield · Well covered
Ranks above peers (8/9)
Moderate moat 49/100
Some data
Weak Growth (revenue 5y +1.6 %/yr in KRW)
⟳ Cyclical

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

57,700 KRW 31,410 KRW Fair Value 124,260 KRW Apr 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.

How to read this chart

60‑month range 31,410 KRW – 57,700 KRW · fair‑value band 97,266 KRW – 167,113 KRW · the 56,600 KRW price screens below the 124,260 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.

Follow KPX Chemical in your weekly email

Every Wednesday you see whether KPX Chemical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

KPX Chemical Co.,Ltd. manufactures and sells organic chemicals and chemical products in South Korea. The company was founded in 1974 and is headquartered in Seoul, South Korea.

Stock analysis

KPX Chemical (025000) currently trades at 56,600 KRW, while our model-based Fair Value estimate is 124,260 KRW, implying the stock looks roughly 54.5% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 158,457 KRW per share, and 20 of the 24 models we run sit above the 56,600 KRW price.

Bear case: the Dividend Discount group reads lowest at 30,351 KRW, and 4 of the 24 models stay below the price. Evidence for this calculation is medium.

Scenario range: 97,266 KRW (bear) to 167,113 KRW (bull), the price of 56,600 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector.

Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

KPX Chemical reported revenue of 808B KRW in FY2025 versus 1.0T KRW in FY2021, a compound −5.7%/yr. Reported net income was 50.6B KRW in FY2025, compounding +1.3%/yr from FY2021.

Key figures

Market cap 248B KRW (≈ $185M) · P/S ratio 0.28 · Dividend yield 7.5% · Net margin 6.3% · Return on equity 13.5% · Return on assets (EBIT) 5.3% · Operating margin 9.4% · Revenue (TTM) 841B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 2% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −24% fair-value upside, at 120%, 025000 screens cheaper than that median.

Fair Value models

Bear 97,266 KRW Fair Value 124,260 KRW Bull 167,113 KRW
Price 56,600 KRW · Upside +119.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 112,438 KRW 136,815 KRW 178,822 KRW 82
Growth DCF 114,728 KRW 137,754 KRW 174,242 KRW 80
Owner Earnings 112,198 KRW 136,518 KRW 178,427 KRW 78
All 24 models by family
DCF Models
FCF DCF 112,438 KRW 136,815 KRW 178,822 KRW 82
Owner Earnings 112,198 KRW 136,518 KRW 178,427 KRW 78
5Y Revenue Exit 87,613 KRW 111,200 KRW 146,251 KRW 74
5Y EBITDA Exit 103,507 KRW 138,327 KRW 185,601 KRW 76
5Y P/E Exit 129,203 KRW 182,186 KRW 246,908 KRW 71
10Y Revenue Exit 97,625 KRW 116,184 KRW 135,637 KRW 68
10Y EBITDA Exit 107,109 KRW 131,038 KRW 156,437 KRW 70
10Y P/E Exit 120,536 KRW 155,053 KRW 188,843 KRW 65
Earnings-Based
Graham-Dodd 83,038 KRW 120,834 KRW 142,467 KRW 67
EPV 43,854 KRW 47,897 KRW 51,178 KRW 74
Dividend Discount
Gordon GGM 27,661 KRW 30,351 KRW 33,590 KRW 69
DDM Multi-Stage 27,661 KRW 33,079 KRW 39,124 KRW 67
Multiples
P/E Multiple 155,697 KRW 207,596 KRW 259,495 KRW 63
P/S Multiple 155,697 KRW 207,596 KRW 259,495 KRW 58
P/B Multiple 155,697 KRW 207,596 KRW 259,495 KRW 55
EV/EBIT 79,532 KRW 102,655 KRW 125,778 KRW 66
EV/EBITDA 109,461 KRW 142,560 KRW 175,660 KRW 67
EV/Revenue 70,283 KRW 96,048 KRW 121,814 KRW 54
Asset-Based
NCAV (Graham) 79,121 KRW 106,022 KRW 158,242 KRW 54
Growth DCF
Growth DCF 114,728 KRW 137,754 KRW 174,242 KRW 80
Rev-Margin DCF 87,613 KRW 114,038 KRW 148,318 KRW 74
Economic Profit
Residual Income 120,082 KRW 125,146 KRW 134,468 KRW 76
ROIC Compounder 43,854 KRW 47,897 KRW 51,178 KRW 72
Growth Earnings
Growth-Adj P/E 110,920 KRW 158,457 KRW 205,994 KRW 67

Open the full fair value analysis →

Notify me when 025000 reaches fair value

Put 025000 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 60/100

Of which business quality 58 · Market factors (momentum, volatility) 78

Profitability 42
Margins and returns on capital today
Quality Growth 28
Are margins and returns improving?
Cashflow 53
Earnings quality: real cash, not paper profit
Fin. Strength 73
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 91
Calm price path (market factor)
Momentum 67
Price trend over the last 3–12 months (market factor)
52W Momentum 82
Distance to the 52-week high (market factor)
Net Issuance 79
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−6.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.6%
Start year 2020 (pandemic). Over 10 years: +0.8% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.7%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+10.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.7%
Dividend (yield on the price)7.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.2.7% vs 5.5%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 3%
Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−10.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −12.5% a year for the price.

Watch 025000, get fair value alerts →

Compare KPX Chemical with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 343 stocks

Beats the industry median on 8/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 60 · Above median
Fair Value upside +119.5% · Top 25%
Profitability
Return on equity (TTM) 13.5% · Top 25%
Return on assets 2.6% · Below median
Net margin (TTM) 12.3% · Top 25%
Operating margin (TTM) 9.4% · Above median
Growth and dividend
Revenue growth 22.9% · Above median
Dividend yield (TTM) 7.5% · Top 25%
Balance sheet
Debt / equity 0.00× · Lowest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 3
FUTURE (revenue growth)100 · sector 63
PAST (return on equity)54 · sector 23
HEALTH (low debt)100 · sector 94
DIVIDEND (yield)100 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
BASF SE BAS €49.93 €24.40 −51%
Ningxia Baofeng Energy Group 600989 ¥22.33 ¥40.44 +81%
Dow Inc DOW $27.59 $20.98 −24%
Hengli Petrochemical Co 600346 ¥16.15 ¥43.28 +168%
Zangge Mining Company 000408 ¥71.46 ¥78.61 +10%
LG Chem, Ltd 051910 252,500 KRW 587,755 KRW +133%
Zhejiang Juhua Co 600160 ¥33.97 ¥19.25 −43%
Jiangsu Eastern Shenghong Co 000301 ¥13.36 ¥3.06 −77%
Formosa Chemicals & Fibre Corporation 1326 67.00 TWD 17.68 TWD −74%
Syensqo SA SYENS €78.20 €32.87 −58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "KPX Chemical Fair Value". https://www.fairvalue-calculator.com/stock/025000

Frequently asked questions

Is KPX Chemical (025000) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of 124,260 KRW versus a price of 56,600 KRW, about +120% upside (undervalued).
What is the fair value of 025000?
Our model-based fair value for KPX Chemical is 124,260 KRW (as of Oct 2, 2026), built from audited fundamentals. The current price: 56,600 KRW.
What is the quality score of 025000?
KPX Chemical has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for KPX Chemical (025000)?
Our model-based price target is the fair value of 124,260 KRW (as of Oct 2, 2026) from 24 valuation models. Cautious scenario 97,266 KRW, optimistic scenario 167,113 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the KPX Chemical stock forecast for 2026?
Our models put fair value at 124,260 KRW, about +120% upside versus a price of 56,600 KRW (undervalued). Cautious scenario 97,266 KRW, optimistic scenario 167,113 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of KPX Chemical (025000)?
KPX Chemical reported trailing-twelve-month revenue of about 841B KRW (latest available figure, as of Oct 2, 2026).
Does KPX Chemical pay a dividend?
KPX Chemical currently shows a dividend yield of about 7.51% relative to its recent price (as of Oct 2, 2026).
What growth is priced into KPX Chemical (025000)?
For today's price to be fair in a discounted-cash-flow model, KPX Chemical would have to grow free cash flow by -10.7 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +1.6 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of 025000 use?
Our models discount KPX Chemical at 11.6 %: a base by market capitalisation (micro), damped by beta 0.31, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For KPX Chemical that is -10.7 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has KPX Chemical (025000) delivered so far?
Over the past 5 years revenue at KPX Chemical grew +1.6 % a year. The price currently implies -10.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of KPX Chemical (025000) growing?
The median revenue growth in the sector is +8.9 % a year. That is the yardstick for the growth priced into KPX Chemical (-10.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of KPX Chemical (025000)?
The free-cash-flow yield on the price is 22.41 %: that much free cash flow KPX Chemical produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of KPX Chemical (025000)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For KPX Chemical it is 124,260 KRW per share (as of Oct 2, 2026), against a price of 56,600 KRW. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is KPX Chemical stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 025000 trades below its calculated fair value: price 56,600 KRW, fair value 124,260 KRW, a gap of about +120% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 025000?
No. The price is what the market pays today (56,600 KRW); the fair value is what the company's own numbers justify (124,260 KRW). For KPX Chemical the two are 67,660 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is KPX Chemical worth?
The market values KPX Chemical at about 248B KRW (market capitalisation, as of Oct 2, 2026). Per share that is 56,600 KRW; our models calculate a fair value of 124,260 KRW per share.
What do the bullish and bearish scenarios say about 025000?
Our models span a range for KPX Chemical: cautious scenario 97,266 KRW, base 124,260 KRW, optimistic 167,113 KRW per share (as of Oct 2, 2026, price 56,600 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of KPX Chemical (025000)?
Balance-sheet figures for KPX Chemical (as of Oct 2, 2026): return on equity 13.5%, debt of 0.00 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is 025000 from its 52-week high?
KPX Chemical trades at 56,600 KRW, about 2% below its 52-week high of 57,700 KRW and 36% above the low of 41,541 KRW (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 124,260 KRW is for.
Which stocks are comparable to KPX Chemical?
From the same area (Basic Materials) we also value BASF SE, Ningxia Baofeng Energy Group, Dow Inc, Hengli Petrochemical Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is KPX Chemical stock attractive at the current price?
The data as of Oct 2, 2026: price 56,600 KRW, calculated fair value 124,260 KRW (+120%), Quality Score 60/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 025000 calculated?
We run KPX Chemical through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 124,260 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. KPX Chemical currently trades 54 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of KPX Chemical (025000)?
The closing price on Oct 2, 2026 was 56,600 KRW. Our model-based fair value is 124,260 KRW, about +120% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with KPX Chemical right now?
The price is below even our cautious bear case (97,266 KRW). The market is more pessimistic than our downside scenario. Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of KPX Chemical

How large is the market capitalisation of KPX Chemical (025000)?
The market capitalisation of KPX Chemical is 248B KRW (≈ $185M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of KPX Chemical (025000)?
The price-to-sales ratio of KPX Chemical is 0.28 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of KPX Chemical (025000)?
The dividend yield of KPX Chemical is 7.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of KPX Chemical (025000)?
The net margin of KPX Chemical is 6.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of KPX Chemical (025000)?
The return on equity (ROE) of KPX Chemical is 13.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of KPX Chemical (025000)?
On an EBIT basis the return on assets of KPX Chemical is 5.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of KPX Chemical (025000)?
The operating margin of KPX Chemical is 9.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at KPX Chemical (025000)?
Revenue at KPX Chemical is growing +22.9% versus a year earlier (3y avg −6.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at KPX Chemical (025000)?
Earnings per share at KPX Chemical are growing +314% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does KPX Chemical (025000) carry?
The net debt of KPX Chemical is 53.8B KRW (fiscal year 2025, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch KPX Chemical in the live analysis

One click puts KPX Chemical on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.